US·Bill·117th Congress
HR 4479
Facilitating Innovative Nuclear Diagnostics Act of 2021
Introduced 2021-07-16Last action 2021-07-19 — Referred to the Subcommittee on Health.Committees House Committee on Energy and Commerce, House Committee on Ways and Means
Sponsor
Cosponsors (41)
Armstrong, Kelly(R-ND)Auchincloss, Jake(D-MA)Blunt Rochester, Lisa(D-DE)Bucshon, Larry(R-IN)Burchett, Tim(R-TN)Carbajal, Salud O.(D-CA)Carson, André(D-IN)Carter, Earl L. "Buddy"(R-GA)Craig, Angie(D-MN)Cárdenas, Tony(D-CA)Dunn, Neal P.(R-FL)Ferguson, A.(R-GA)Johnson, Bill(R-OH)Joyce, John(R-PA)Krishnamoorthi, Raja(D-IL)Kuster, Ann(D-NH)Lieu, Ted(D-CA)Lowenthal, Alan(D-CA)Malinowski, Tom(D-NJ)McGovern, James P.(D-MA)McKinley, David(R-WV)Miller-Meeks, Mariannette(R-IA)Moulton, Seth(D-MA)Mullin, Markwayne(R-OK)Murphy, Gregory F.(R-NC)Pappas, Chris(D-NH)Payne, Donald(D-NJ)Phillips, Dean(D-MN)Posey, Bill(R-FL)RUSH, BOBBY(D-IL)Reschenthaler, Guy(R-PA)Rutherford, John H.(R-FL)Sewell, Terri A.(D-AL)Smith, Adrian(R-NE)Smith, Christopher H.(R-NJ)Soto, Darren(D-FL)Tonko, Paul(D-NY)Trahan, Lori(D-MA)Van Drew, Jefferson(R-NJ)Walorski, Jackie(R-IN)Watson Coleman, Bonnie(D-NJ)
⚫
Died in committee
The 117th Congress ended on 2023-01-03. This bill was in committee when the session adjourned and did not advance to enactment.
Legislative Progress
✓
Introduced
✗
In Committee
3
Passed Chamber
4
Enacted / Signed
Action History
Referred to the Subcommittee on Health.
2021-07-16 · House committee actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2021-07-16 · House floor actions
Introduced in House
2021-07-16 · Library of Congress
Referred to the Subcommittee on Health.
2021-07-19 · House committee actions
Summary
Facilitating Innovative Nuclear Diagnostics Act of 2021
This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2022 and as adjusted based on a specified fee schedule factor in each year thereafter.
Full Bill Text
https://www.congress.gov/bill/117th-congress/hr/4479